ClickCease
+1-915-850-0900 spinedoctors@gmail.com
Select Page

Wellness

Clinic Wellness Team. A key factor to spine or back pain conditions is staying healthy. Overall wellness involves a balanced diet, appropriate exercise, physical activity, restful sleep, and a healthy lifestyle. The term has been applied in many ways. But overall, the definition is as follows.

It is a conscious, self-directed, and evolving process of achieving full potential. It is multidimensional, bringing together lifestyles both mental/spiritual and the environment in which one lives. It is positive and affirms that what we do is, in fact, correct.

It is an active process where people become aware and make choices towards a more successful lifestyle. This includes how a person contributes to their environment/community. They aim to build healthier living spaces and social networks. It helps in creating a person’s belief systems, values, and a positive world perspective.

Along with this comes the benefits of regular exercise, a healthy diet, personal self-care, and knowing when to seek medical attention. Dr. Jimenez’s message is to work towards being fit, being healthy, and staying aware of our collection of articles, blogs, and videos.


Functional Medicine: Consolidated Glossary

Functional Medicine: Consolidated Glossary

Functional Medicine: Glossary

 

man doing bar arm curlsAllostasis: The process of achieving stability, or homeostasis, through physiological or behavioral change. This can be carried out by means of alteration in HPATG axis hormones, the autonomic nervous system, cytokines, or a number of other systems, and is generally adaptive in the short term. It is essential in order to maintain internal viability amid changing conditions.

Antecedents: Factors that predispose to acute or chronic illness. For a person who is ill, antecedents form the illness diathesis. From the perspective of prevention, they are risk factors. Examples of genetic antecedents include the breast cancer risk genes BRCA1 and BRCA2.

functional medicine apoptosis necrosis

Apoptosis: Programmed cell death. As a normal part of growth and development, cells that are superfluous or that become damaged activate a cascade of intracellular processes leading to their own demise. In cancer cells, DNA damage may inactivate the apoptosis cascade, allowing mutated cells to survive and proliferate.

Biochemical individuality: Each individual has a unique physiological and biochemical composition, based upon the interactions of his or her individual genetic make-up with lifestyle and environment�i.e., the continuous exposure to inputs (diet, experiences, nutrients, beliefs, activity, toxins, medications, etc.) that influence our genes. It is this combination of factors that accounts for the endless variety of phenotypic responses seen every day by clinicians. The unique makeup of each individual requires personalized levels of nutrition and a lifestyle adapted to that individual�s needs in order to achieve optimal health. The consequences of not meeting the specific needs of the individual are expressed, over time, as degenerative disease.

Bioidentical Hormone Therapy: Giving exogenous hormones that are identical in structure to the endogenous hormones.

Biomarker: A substance used as an indicator of a biological state. Such characteristics are objectively measured and evaluated as indicators of normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. Cancer biomarkers include prostate specific antigen (PSA) and carcinoembryonic antigen (CEA).

Biotransformation: The chemical modification(s) of a compound made by an organism. Compounds modified in the body include, but are not limited to, nutrients, amino acids, toxins, heavy metals, and drugs. Biotransformation also renders nonpolar compounds polar so that they are excreted, not reabsorbed in renal tubules.

Cancer: A group of diseases characterized by uncontrolled growth and spread of abnormal cells, which, if not controlled, can result in death. Cancer is caused by both external factors (tobacco, infectious organisms, chemicals, and radiation) and internal factors (inherited mutations, hormones, immune conditions, and mutations that occur from metabolism), two or more of which may act together or in sequence to initiate or promote carcinogenesis. Ten or more years often pass between exposure to external factors and detectable cancer.

functional medicine Chronic Care ModelChronic Care Model: Developed by Wagner and colleagues, the primary focus of this model is to include the essential elements of a healthcare system that encourage high-quality chronic disease care. Such elements include the community, the health system, self-management support, delivery system design, decision support and clinical information systems. It is a response to powerful evidence that patients with chronic conditions often do not obtain the care they need, and that the healthcare system is not currently structured to facilitate such care.

functional medicine herbal tea complimentary medicineComplementary and Alternative Medicine (CAM): A group of diverse medical and healthcare systems, practices, and products that are not presently considered to be part of conventional, mainstream medicine. The list of what is considered to be CAM changes frequently, as therapies demonstrated to be safe and effective are adopted by conventional practitioners, and as new approaches to health care emerge. Complementary medicine is used with conventional medicine, not as a substitute for it. Alternative medicine is used in place of conventional medicine. Functional medicine is neither complementary nor alternative medicine; it is an approach to medicine that focuses on identifying and ameliorating the underlying causes of disease; it can be used by all practitioners with a Western medical science background and is compatible with both conventional and CAM methods.

functional medicineCytochromes P450 (CYP 450): A large and diverse group of enzymes, most of which function to catalyze the oxidation of organic substances. They are located either in the inner membrane of mitochondria or in the endoplasmic reticulum of cells ans play a critical role in the detoxification of endogenous and exogenous toxins. The substrates of CYP enzymes include metabolic intermediates such as lipids, steroidal hormones, and xenobiotic substances such as drugs.

DIGIN: A heuristic mnemonic for assessment of gastrointestinal dysfunction. Thorough assessment of the GI tract should include investigation of the following:

  • Digestion/Absorption � Problems with the digestive process including ingestion, chemical digestion, mechanical digestion, absorption, and/or assimilation
  • Intestinal Permeability � Permeability of the intestinal barrier: is the epithelium allowing in larger particles in a paracellular manner, making the gut barrier �leaky�?
  • Gut Microbiota/Dysbiosis � Changes in composition of the gut flora including balance and interaction of commensal species (See: Dysbiosis)
  • Inflammation/Immune � Inflammation and immune activity in the GI tract
  • Nervous System � Enteric nervous system function, which controls motility, blood flow, uptake of nutrients, secretion, and immunological and inflammatory processes in the gut.

functional medicineDysbiosis: A condition that occurs when the normal symbiosis between gut flora and the host is disturbed and organisms of low intrinsic virulence, which normally coexist peacefully with the host, may promote illness. It is distinct from gastrointestinal infection, in which a highly virulent organism gains access to the gastrointestinal tract and infects the host.

Functional Medicine: A systems-based, science-driven approach to individualized medicine that addresses the underlying causes of disease, using a systems-oriented approach and engaging both patient and practitioner in a therapeutic partnership. It reflects a personalized lifestyle medicine approach and utilizes the Functional Medicine Matrix to organize the patient�s story and determine appropriate interventions for the prevention and treatment of chronic diseases.

functional medicine Functional Medicine MatrixFunctional Medicine Matrix: The graphic representation of the functional medicine approach, displaying the seven organizing physiological systems, the patient�s known antecedents, triggers, and mediators, and the personalized lifestyle factors that promote health. Practitioners can use the matrix to help organize their thoughts and observations about the patient�s health and decide how to focus therapeutic and preventive strategies.

Cytokines: Immunoregulatory proteins (such as interleukin, tumor necrosis factor, and interferon). They may act locally or systemically and tend to have both immunomodulatory and other effects on cellular processes in the body. Cytokines have been used in the treatment of certain cancers.

Genomics: The study of the whole genome of organisms, including interactions between loci and alleles within the genome. Research on single genes does not fall into the definition of genomics unless the aim of this functional information analysis is to elucidate the gene�s effect on the entire genome network. Genomics may also be defined as the study of all the genes of a cell, or tissue, at the DNA (genotype), mRNA (transcriptome), or protein (proteome) levels.

GO-TO-IT: A heuristic mnemonic for the processes involved in the clinical practice of functional medicine:

  • Gather oneself and be mindful in preparing to see each patient; gather information through intake forms, questionnaires, the initial consultation, physical exam, and objective data. A detailed functional medicine history that is appropriate to age, gender, and nature of presenting problems is taken.
  • Organize the subjective and objective details from the patient�s story within the functional medicine paradigm. Position the patient�s presenting signs and symptoms, along with the details of the case history, on the timeline and Functional Medicine Matrix.
  • Tell the story back to the patient in your own words to ensure accuracy and understanding. The re-telling of the patient�s story is a dialogue about the case highlights�including the antecedents, triggers, and mediators identified in the history and correlating them to the timeline and matrix. The patient is asked to correct and amplify the story, engendering a context of true partnership.
  • Order and then prioritize the patient�s information:
  • Acknowledge patient�s goals
  • Address modifiable lifestyle factors
  • Sidney Baker�s too much/not enough model: what are the insufficiencies/excesses?
  • Identify clinical imbalances or disruptions in the organizing physiological systems of the matrix
  • Initiate further functional assessment and intervention based upon the above work:
  • Perform further assessment
  • Referral to adjunctive care:
    1. Nutritional professionals
    2. Lifestyle educators
    3. Other healthcare providers
    4. Specialists
  • Initiate therapy
  • Track assessments, note the effectiveness of the therapeutic approach, and identify clinical outcomes at each visit�in partnership with the patient.

Heuristic: A strategy used for problem solving, learning, and discovery that is experience-based, not algorithmic. When an exhaustive search is impractical, heuristic methods may be used to speed up the process of finding a satisfactory solution. A heuristic is sometimes referred to as a rule of thumb.

Homeostasis and Homeodynamics: The former term describes the tendency of living things to maintain physiological parameters within a narrow range usually considered normal in order to maintain optimal function. Under this definition, disease can be defined as a departure from the homeostatic state. The latter term describes the tendency of homeostatic set points to change throughout an organism�s lifespan, and thus describes how departures from a homeostatic norm can be adaptive (e.g., fever) or pathological, depending on the context.

Integrative Medicine: Medicine that combines treatments from conventional medicine and those from Complementary and Alternative Medicine (CAM) for which there is some high-quality evidence of safety and effectiveness. In a broader sense, it is healing-oriented medicine that takes into account the whole person (body, mind, and spirit), including all aspects of lifestyle, and makes use of all appropriate therapies, both conventional and alternative. The field is more than 10 years old and it is the only one of the emerging models to explicitly encompass the integration of therapeutics that, until recently, were the sole purview of complementary and alternative medicine. Note: functional medicine is different from integrative medicine because functional medicine emphasizes the evaluation of underlying causes of health and dysfunction and organizes assessment and treatment using the Functional Medicine Matrix, the timeline, and GOTOIT.

functional medicine lady roller bladingLifestyle Medicine: The use of lifestyle interventions such as nutrition, physical activity, stress reduction, and rest to lower the risk for the approximately 70% of modern health problems that are lifestyle-related chronic diseases (such as obesity and type 2 diabetes), or for the treatment and management of disease if such conditions are already present. It is an essential component of the treatment of most chronic diseases and has been incorporated in many national disease management guidelines.

 

Long Latency Disease: Disease that becomes manifest at a time remote from the initial exposure to disease triggers, or that requires continued exposure to triggers and mediators over an extended period of time to manifest frank pathology. Examples include heart disease, cancer, and osteoporosis.

Mediators: Intermediaries that contribute to the continued manifestations of disease. Mediators do not cause disease; instead, they underlie the host response to triggers. Examples include biochemical factors (e.g., cytokines and leukotrienes) as well as psychosocial ones (e.g., reinforcement for staying ill).

Metabolomics (or metabonomics): �The study of metabolic responses to drugs, environmental changes and diseases. Metabonomics is an extension of genomics (concerned with DNA) and proteomics (concerned with proteins). Following on the heels of genomics and proteomics, metabonomics may lead to more efficient drug discovery and individualized patient treatment with drugs, among other things.� (From MedicineNet.com)

Nutrigenomics (or nutritional genomics): The study of how different foods may interact with specific genes to increase the risk of common chronic diseases such as type 2 diabetes, obesity, heart disease, stroke, and certain cancers. It can also be described as the study of the influence of genetic variation on nutrition by correlating gene expression or single-nucleotide polymorphisms with a nutrient’s absorption, metabolism, elimination, or biological effects. Nutrigenomics also seeks to provide a molecular understanding of how common chemicals in the diet affect health by altering the expression of genes and the structure of an individual’s genome. The ultimate aim of nutrigenomics is to develop rational means to optimize nutrition for the patient�s genotype.

Organ Reserve: The difference between the maximal function of a vital organ and the level of function required to maintain an individual�s daily life. In other words, it is the �reserve power� of a particular organ, above and beyond what is required in a healthy individual. It can also be thought of as the degrees of freedom available in the body organs to perform their functions and maintain health. Decline in the organ reserve occurs under stress, during sickness, and as we age.

Organ System Diagnosis: In the allopathic medical model, it is common to give a collection of symptoms a name based on dysfunction in an organ system, then to cite the named disease as the cause of the symptoms the patient is experiencing. This bit of circular logic avoids any discussion of the systemic or underlying causes of dysfunction and also treats all people with �disease X� the same, despite the fact that two people with the same collection of symptoms may have completely different underlying physiological causes for the symptoms they display.

Organizing Physiological Systems: To assist clinicians in understanding and applying the complexity of functional medicine, IFM has organized and adapted a set of seven interrelated biological systems that underlie all physiology. Imbalances in these systems or core clinical imbalances are the underlying cause of disease and dysfunction.

  • Assimilation (e.g., Digestion, Absorption, Microbiota/GI, Respiration)
  • Defense and Repair (e.g., Immune, Inflammation, Infection/Microbiota)
  • Energy (e.g., Energy Regulation, Mitochondrial Function)
  • Biotransformation and Elimination (e.g., Toxicity, Detoxification)
  • Transport (e.g., Circulation, Lymphatic Flow)
  • Communication (e.g., Endocrine, Neurotransmitters, Immune messengers)
  • Structural Integrity (e.g., from Subcellular Membranes to Musculoskeletal Structure)

Using this construct, it becomes much clearer that one disease/condition may have multiple causes (i.e., multiple clinical imbalances), just as one fundamental imbalance may be at the root of many seemingly disparate conditions.

Oxidation-Reduction (also called Redox): Paired chemical reactions that occur in balance with each other within the body of a healthy individual. These reactions involve the transfer of electrons (or the distribution of electron sharing) and thus require both a donor and acceptor. When this physiological parameter is out of balance, a net accumulation of donors or acceptors can lead to deleterious cellular oxidation phenomena (lipid peroxidation, free radical formation).

Oxidative Stress: Oxidative stress occurs when there is an imbalance between the production of damaging reactive oxygen species and an individual�s antioxidant capacity to detoxify the reactive intermediates or to repair the resulting damage. Disturbances in the normal redox state of tissues can cause toxic effects through the production of peroxides and free radicals that damage all components of the cell, including proteins, lipids, and DNA. Oxidative stress is implicated in the etiology of several chronic diseases including atherosclerosis, Parkinson’s disease, Alzheimer’s disease, and chronic fatigue syndrome.

Personalized Lifestyle Factors: The modifiable lifestyle factors that appear along the bottom of the Functional Medicine Matrix. Clinicians and their patients can partner to develop an individualized plan for addressing these issues. Health-promoting lifestyle factors include:

  • Sleep and Relaxation � Getting adequate sleep and meaningful relaxation time in one�s life
  • Exercise and Movement � Participating in physical activity that is appropriate for age and health
  • Nutrition and Hydration � Eating a diet that is appropriate for age, genetic background, and environment, as well as maintaining adequate hydration
  • Stress and Resilience � Reducing stress levels and managing existing stress
  • Relationships and Networks � Developing and maintaining healthy relationships and social networks while reducing the impact of noxious relationships

Personalized (Individualized) Medicine: Personalized medicine can be described as the effort to define and strengthen the art of individualizing health care by integrating the interpretation of patient data (medical history, family history, signs, and symptoms) with emerging ��omic� technologies�nutritional genomics, pharmacogenomics, proteomics, and metabolomics. It is also defined as medicine that treats each patient as a unique individual and takes into account the totality of personal history, family history, environment and lifestyle, physical presentation, genetic background, and mind/body/spirit. Interventions are tailored to each patient and adjusted based on the patient�s individualized response.

Precipitating Event: Similar to a trigger�a trigger, however, only provokes illness as long as the person is exposed to it (or for a short while afterward), while a precipitating event initiates a change in health status that persists long after the exposure ends

Prospective Medicine (aka: 4-P Medicine): A relatively new concept introduced in 2003, prospective medicine is a descriptive rather than a prescriptive term, encompassing �personalized, predictive, preventive, and participatory medicine.� Snyderman argues persuasively that a comprehensive system of care would address not only new technologies (e.g., identification of biomarkers, use of electronic and personalized health records), but also delivery systems, reimbursement mechanisms, and the needs of a variety of stakeholders (government, consumers, employers, insurers, and academic medicine). Prospective medicine does not claim to stake out new scientific or clinical territory; instead, it focuses on creating an innovative synthesis of technologies and models�particularly personalized medicine (the �-omics�) and systems biology�in order to �determine the risk for individuals to develop specific diseases, detect the disease�s earliest onset, and prevent or intervene early enough to provide maximum benefit.

Proteomics: The large-scale study of proteins, particularly their structures and functions, how they’re modified, when and where they’re expressed, how they’re involved in metabolic pathways, and how they interact with one another. The proteome is the entire complement of proteins, including the modifications made to a particular set of proteins, produced by an organism or system. This will vary with time and distinct requirements, or stresses, that a cell or organism undergoes. As a result, proteomics is much more complicated than genomics: an organism’s genome is more or less constant, while the proteome differs from cell to cell and from time to time.

PURE: A heuristic mnemonic for assessment and treatment of toxicity-related disorders. Steps to consider when assessing and treating patients with toxic exposures include:

  • Pattern Recognition � Recognize common patterns of toxicity signs and symptoms, including those associated with neurodevelopmental toxicity, immunotoxicity, mitochondrial toxicity, and endocrine toxicity
  • Undersupported/Overexposed � Examine the patient�s environment and lifestyle to determine what might be lacking and what there might be too much of
  • Reduce Toxin Exposure � Design a strategy for the patient to avoid continued toxin exposure
  • Ensure a Safe Detox � Support the patient during detoxification by ensuring adequate nutrients to aid in the detoxification and biotransformation process and by recommending lifestyle changes that increase the safety and efficacy of detox programs.

PTSD: A heuristic for general treatment of hormone-related disorders. Factors to be considered include:

  • Production � Production/synthesis and secretion of the hormone
  • What are the building blocks of thyroid hormone and cortisol?
  • What affects the secretion of insulin?
  • What are the building blocks of serotonin?
  • What affects synthesis-inflammation of the gland (as in autoimmune thyroiditis)?
  • Transport � Transport/conversion/distribution/ interaction with other hormones
  • Do the levels of insulin impact the levels of E or T?
  • Does a hormone�s transport from its gland of origin to the target gland impact its effectiveness or toxicity?
  • Can we influence the level of free hormone?
  • Is the hormone transformed (T4 to T3 or RT3) and can we modulate that?
  • Sensitivity � Cellular sensitivity to the hormone signal
  • Are there nutritional or dietary factors that influence the cellular response to insulin, thyroid hormones, estrogens, etc.?
  • Detoxification � Detoxification/excretion of the hormone. For example:
  • How is estradiol metabolized in the process of biotransformation?
  • Can we alter it?
  • What can we do to affect the binding to and excretion of estrogens?

functional medicineSingle Nucleotide Polymorphism or SNP (pronounced �snip�) is a DNA sequence variation occurring when a single nucleotide�A, T, C, or G�in the genome differs between members of a species or between paired chromosomes in an individual. Almost all common SNPs have only two alleles. These genetic variations underlie differences in our susceptibility to, or protection from, several diseases. Variations in the DNA sequences of humans can affect how humans develop diseases. For example, a single base difference in the genes coding for apolipoprotein E is associated with a higher risk for Alzheimer’s disease. SNPs are also manifestations of genetic variations in the severity of illness, the way our body responds to treatments, and the individual response to pathogens, chemicals, drugs, vaccines, and other agents. They are thought to be key factors in applying the concept of personalized medicine.

Relative Risk: A measure of the strength of the relationship between risk factors and a condition. For example, one could compare the risk of developing cancer in persons with a certain exposure or trait to the risk in persons who do not have this characteristic. Male smokers are about 23 times more likely to develop lung cancer than nonsmokers, so their relative risk is 23. Most relative risks are not this large. For example, women who have a first-degree relative (mother, sister, or daughter) with a history of breast cancer have about twice the risk of developing breast cancer compared to women who do not have this family history.

Systems Biology: Although there is not yet a universally recognized definition of systems biology, the National Institute of General Medical Services (NIGMS) at NIH provides the following explanation: �A field that seeks to study the relationships and interactions between various parts of a biological system (metabolic pathways, organelles, cells, and organisms) and to integrate this information to understand how biological systems function.�

The 5Rs: A heuristic mnemonic for the five-step process used to normalize gastrointestinal function that is a core element of functional medicine:

  1. Remove � Removing the source of the imbalance (e.g., pathogens, allergic foods) is the critical first step.
  2. Replace � Next replace any factors that are missing (e.g., HCL, digestive enzymes)
  3. Reinoculate � Repopulate the gut with symbiotic bacteria (e.g., lactobacilli, bifidobacteria)
  4. Repair � Heal damaged gut membranes using, for example, glutamine, fiber, and butyrate
  5. Rebalance � Modify attitude, diet, and lifestyle of the patient to promote a healthier way of living

Three Legs of the Stool: A framework for practicing functional medicine that includes three parts:

  1. Retelling the patient�s story with ATMs (antecedents, triggers, and mediators): The clinician collects information from the patient through extensive interaction, then reflects the problem back to the patient in terms of antecedents, triggers, and mediators
  2. Organizing the clinical imbalances: The clinician organizes the clinical imbalances in the organizing physiological systems and lists them on the Functional Medicine Matrix.
  3. Personalized lifestyle factors: The clinician assesses each patient�s environment and lifestyle, and partners with patients to help them develop, adopt, and maintain appropriate personalized health-promoting behaviors.

Timeline: A tool that allows clinicians to visualize a patient�s story chronologically by organizing important life events and health issues from pre-conception to the present.

functional medicine biological cellsTriage Theory: Linus Pauling Award winner Bruce Ames� theory that DNA damage and late onset disease are consequences of a �triage allocation mechanism� developed during evolution to cope with periods of micronutrient shortage. When micronutrients (vitamins and minerals) are scarce, they are consumed for short-term survival at the expense of long-term survival. In 2009, Children�s Hospital and Research Center Oakland concluded that triage theory explains how diseases associated with aging like cancer, heart disease, and dementia (and the pace of aging itself) may be unintended consequences of mechanisms developed during evolution to protect against episodic vitamin/mineral shortages.

Triggers: Triggers are discrete entities or events that provoke disease or its symptoms (e.g., microbes). Triggers are usually insufficient in and of themselves for disease formation, however, because the health of the host and the vigor of its response to a trigger are essential elements.

functional medicineXenobiotics: Chemicals found in an organism that are not normally produced by or expected to be present in that organism. This may also include substances present in much higher concentrations than usual. The term xenobiotics is often applied to pollutants such as dioxins and polychlorinated biphenyls, because xenobiotics are understood as substances foreign to an entire biological system, i.e. artificial substances that did not exist in nature before their synthesis by humans. Exposure to several types of xenobiotics has been implicated in cancer risk.

 

A Healthier You

Functional Medicine: Understanding Thyroid Lab Tests | Wellness Clinic

Functional Medicine: Understanding Thyroid Lab Tests | Wellness Clinic

Hypothyroidism, or low thyroid function, is among the most frequent chronic hormonal problem on the planet. With approximately 20 million instances in America alone and 200 million people affected globally, hypothyroidism is a silent epidemic. What’s worse is that about half of those struggling with this health issue are undiagnosed.

 

How can people know they have a thyroid disease?

 

Living with weight gain, fatigue, hair loss, brain fog, depression, nervousness or gastrointestinal problems can cause pain and discomfort, often making the individual feel hopeless. If your thyroid is not functioning well, nothing within your body works properly. Many people will visit their healthcare specialists to have lab tests. In case your thyroid-stimulating hormone, or TSH, is out of this lab range, you are given Synthroid, or even levothyroxine. If the labs are “normal,” you’re typically shipped home, without any choices left for a traditional medicine approach.

 

“Normal” Lab Ranges for Thyroid Issues

 

Should you still have low thyroid symptoms and your TSH is “normal”, something is not being addressed. How can we get the “normal” lab range anyhow? The reference array is based on a statistical average of the lab’s populace. That is, other than vitamin D and cholesterol levels, laboratory reference ranges will change depending upon the lab.

 

The people who normally have work done on labs are mathematically not the weakest segment of the population. So if the laboratory results are “normal” despite them having symptoms, what your healthcare professional is essentially saying is that you’re the same as a lot of other ill people. In functional medicine, practitioners look at a more narrow range wherever your body functions optimally and you feel great.

 

Functional Medicine Guide To Recognizing Thyroid Labs

 

A functional medicine approach at your thyroid is more in depth than a T4 plus and TSH. Here are a few of the labs functional medicine practitioners perform on their patients and what they mean:

 

TSH

 

Thyroid-stimulating hormone is released from your pituitary gland to communicate with your thyroid gland. It’s sort of like your brain shouting in your thyroid, if your TSH is elevated. Research has linked a lab “normal” TSH of 2.5-3.5 mIU/mL with a 69 percent risk of dying from a heart attack or stroke. Now you can see why the optimal “functional” range is so important for your health, not just on the lookout for labs from the larger reference array.

 

Laboratory Range: .45-5.5 mIU/L

Optimal Range: 1.8-2.5 mIU/L

 

Total T4

 

T4 is mostly inactive from the human body and has to be converted to be usable. This lab gives you a total of bound and unbound forms of T4. Hormones have to be unbound to be utilized by your entire body. Due to this, this lab doesn’t provide the action of T4 to us when quantified alone. T4 is measured together with a T3 uptake.

 

Laboratory Range: 4.5-12 mg/DL

Maximum Range: 6.0-12.0 mg/DL

 

T3 Uptake

 

This lab does not look at T3, but is very helpful at indirectly looking at hormones like testosterone or estrogen and their relation with the binding of thyroid hormones.

 

Reference Range: 22-35%

Optimal Range: 28%-38%

 

Total T3

 

This laboratory shows us the amount of the active thyroid hormone. It permits a healthcare professional to verify your body’s ability also to rule out an overactive thyroid gland and to convert T4 to T3.

 

Lab Range: 80-200 ng/DL

Maximum Range: 100-180 ng/DL

 

Free T4

 

This will let you know the degrees of free or active form of T4. This will be reduced in cases of hypothyroidism but may be normal in early stages of thyroid disorder.

 

Laboratory Range: 0.8-1.8 ng/DL

Optimal Range: 1.0-1.5 ng/DL

 

Free T3

 

This is your thyroid hormone’s more energetic form. Low T3 syndromes are a common dysfunction seen in practice, and also a low level of the hormone is strongly linked to a greater risk of coronary attack. The issue with this if you’re taking a T4 medicine is that the hormone isn’t being converted by your body into T3, though there are other reasons why thyroid medications may not be working properly.

 

Laboratory Range: 2.3-4.2 pg/mL

Maximum Range: 3.0-4.0 pg/mL

 

Reverse T3

 

Stress and cortisol may increase levels of reverse T3, which is an form of the thyroid gland.

 

Reference Range: 8-25 ng/DL

Maximum Range: 9.2-24.1 ng/DL

 

Thyroid Antibodies

 

Elevated levels of thyroid antibodies reveals an attack against the thyroid gland. The majority of low thyroid cases are around the spectrum, the most typical Hashimoto’s disease.

 

Thyroid Peroxidase (TPO) Ab Optimal Range: 0-15 IU/mL

Thyroglobulin Ab Optimal Range: 0-0.9 IU/mL

 

Labs to address the health of your immune system, your microbiome, along with hormones should be considered. Every one of these labs are going to be a first step into finding out which thyroid pattern which you have, and keep in mind there are thyroid dysfunctions that don’t appear on labs.

 

The scope of our information is limited to chiropractic and spinal injuries and conditions. To discuss options on the subject matter, please feel free to ask Dr. Jimenez or contact us at 915-850-0900 .�
 

By Dr. Alex Jimenez

 

Additional Topics: Wellness

 

Overall health and wellness are essential towards maintaining the proper mental and physical balance in the body. From eating a balanced nutrition as well as exercising and participating in physical activities, to sleeping a healthy amount of time on a regular basis, following the best health and wellness tips can ultimately help maintain overall well-being. Eating plenty of fruits and vegetables can go a long way towards helping people become healthy.

 

blog picture of cartoon paperboy big news

 

TRENDING TOPIC: EXTRA EXTRA: About Chiropractic

 

 

Why Functional Medicine is Essential for Hypothyroidism | Wellness Clinic

Why Functional Medicine is Essential for Hypothyroidism | Wellness Clinic

Functional medicine is a natural, medical practice which has been becoming more popular. What is functional medicine, how is it different from traditional, medical practices, and why is it important to know about when managing Hashimoto’s hypothyroidism and high TSH (thyroid stimulating hormone)? Functional medicine addresses thyroid disease by looking at the root causes instead of masking symptoms with surgery or medication, as with conventional treatments.

 

What are the benefits of FM on hypothyroidism?

 

With functional medicine treatment approaches, healthcare practitioners can take a look at the root causes behind the patient’s Hashimoto’s hypothyroidism and TSH, improving your sleep, energy, vitality, and libido. This is the reason why seeing a functional medicine practitioner for Hashimoto’s hypothyroidism, as well as for TSH and other thyroid issues, can improve hormone balance, gut problems, and brain function. Everything within the body functions together.

 

Thyroid Disease: Addressing the Root Causes

 

In the event the motor light of your vehicle is based on, do you find a way to turn off the engine light, or do you research beneath the hood? That analogy works for functional medicine when managing Hashimoto’s hypothyroidism and TSH.

 

Functional medicine is not about providing you a medication for a symptom, but instead investigating why you have that symptom and functioning on this instead. By way of example, assume 10 different people have the same complaint, whether it is depression, fatigue, digestive problems, or persistent skin rashes. Each of these 10 individuals can have the same symptom, but also for 10 very different reasons. An overgrowth of gut bacteria might be causing depression in one individual, while it’s a gluten intolerance in a different. With Hashimoto’s hypothyroidism and high TSH, it is helpful to look at the underlying causes that led to the development of the autoimmune thyroid disorder and address people.

 

Understanding the Reason for Thyroid Disease

 

Until you realize why you are experiencing Hashimoto’s hypothyroidism and higher TSH, following drugs or therapies may keep landing you in dead ends. Functional medicine relies on published, peer-reviewed science to help us understand how the body functions and where breakdowns happen. Lab tests, questionnaires, in-office exams, and a discussion about your case history help the functional medicine practitioner learn where the root cause of your Hashimoto’s hypothyroidism and high TSH lies.

 

Five Common Functional Medicine Root Causes

 

Although different people can have the exact same symptom for different reasons, practical medicine often finds ordinary root causes. Some of them are:

 

  • Autoimmunity (when the immune system attacks and destroys body tissue). In most people, hypothyroidism is brought on by thyroid autoimmunity, which causes TSH.
  • Food intolerances, particularly to gluten and dairy
  • Low Blood Glucose
  • High blood sugar (insulin resistance, or pre-diabetes)
  • Intestinal yeast, bacterial overgrowths, and leaky gut

 

Addressing one or all of these variables, based on the individual, can help you better handle your Hashimoto’s, reduce your TSH, also relieve not only your thyroid symptoms, but a number of other symptoms as well.

 

There are No Specialties in the Human Body

 

The body is an extremely complex web where all systems and parts are related. The body does not have specialties in the way medicine does. The digestive tract — or any other system in your system, doesn’t operate independently of the rest of the human body.

 

For example, if autoimmune disease is destroying the thyroid gland causing high TSH, it is not just the thyroid you tackle, but also the immune system. Addressing a gluten intolerance if the stomach is behaving and chronic inflammation can prevent gallbladder surgery. For instance, with Hashimoto’s and high TSH, it’s not merely the thyroid you address, but also the immune system.

 

The scope of our information is limited to chiropractic and spinal injuries and conditions. To discuss options on the subject matter, please feel free to ask Dr. Jimenez or contact us at 915-850-0900 .�
 

By Dr. Alex Jimenez

 

Additional Topics: Wellness

 

Overall health and wellness are essential towards maintaining the proper mental and physical balance in the body. From eating a balanced nutrition as well as exercising and participating in physical activities, to sleeping a healthy amount of time on a regular basis, following the best health and wellness tips can ultimately help maintain overall well-being. Eating plenty of fruits and vegetables can go a long way towards helping people become healthy.

 

blog picture of cartoon paperboy big news

 

TRENDING TOPIC: EXTRA EXTRA: About Chiropractic

 

 

10 Signs and Remedies for Thyroid Diseases | Wellness Clinic

10 Signs and Remedies for Thyroid Diseases | Wellness Clinic

It’s estimated that as many as 27 million people in the United States have a thyroid issue, such as Hashimoto’s thyroiditis or Graves’ disease, and half of them don’t have any concept that they do. An under-active thyroid, or hypothyroidism, accounts for approximately 90 percent of all thyroid imbalances.

 

What is the thyroid gland?

 

A butterfly-shaped gland in your neck’s center gland, the thyroid gland, is the master gland of metabolism. Your thyroid gland is inter-related with each system in the human body. If your thyroid isn’t running optimally, then neither are you.

 

10 Signs of an Underactive Thyroid:

 

  • Fatigue after sleeping 8 to 10 hours a night or having to take a rest daily
  • Weight gain or the inability to lose weight
  • Mood issues such as mood swings, anxiety, or depression
  • Hormone imbalances such as PMS, irregular periods, infertility, and reduced sex drive
  • Muscle pain, joint pain, carpal tunnel syndrome, or tendonitis
  • Cold hands and feet, feeling cold when others aren’t, or having a body temperature consistently under 98.5
  • Dry or cracking skin, brittle nails and excess hair loss
  • Constipation
  • Head issues like brain fog, poor concentration, or poor memory
  • Neck swelling, snoring, or hoarse voice

 

How Does the Thyroid Gland Function?

 

Thyroid hormone production is regulated by a feedback loop involving the hypothalamus, pituitary gland, and the thyroid gland. Hypothalamic thyrotropin-releasing hormone (TRH) stimulates pituitary thyrotropin (TSH) secretion and synthesis. In turn, TSH stimulates release and production of T4 and T3 in the thyroid gland. It signals that there’s enough thyroid hormone in flow and not to generate more, when T4 is generated.

 

About 85 percent of this hormone produced by our thyroid gland is T4, which is an inactive form of the hormone. Once T4 is made, a little quantity of it is converted. For complicate matters, T3 also gets converted to either Free T3 (FT3) or Reverse T3 (RT3). It is the Free T3 that actually matters in all of this, as it is the only hormone that could attach to a receptor and cause your metabolism to increase its production, keep you warm, keep your bowels moving, keep your mind working, along with keeping other hormones in check. Reverse T3’s part isn’t well known, however, healthcare professionals have seen it increase under intense stress and in people who have allergies.

 

And finally, Hashimoto’s thyroiditis, an autoimmune disease, is the most common form of hypothyroidism and its numbers are increasing annually. An autoimmune disorder is one in which your body turns on itself and begins to attack a certain organ or tissue believing it’s foreign. Many healthcare professionals regularly screen patients for autoimmune thyroid disease by ordering Thyroid Peroxidase Antibodies (TPOAb) and Thyroglobulin Antibodies (TgAb) tests.

 

Why is Hypothyroidism So Under Recognized?

 

Many symptoms of thyroid imbalance are vague and most doctors spend only a few minutes talking with patients to sort out the cause of the complaint. Most conventional doctors use just a couple of tests (TSH and T4) to display for problems. They aren’t assessing the thyroid gland, RT3 , or FT3.

 

Most traditional doctors utilize the ‘normal’ laboratory reference range as their guide only. Rather than listening to their patients symptoms, they use ‘optimal’ laboratory values and temperature as their guide.

 

Which laboratory tests are better to ascertain if you’ve got a thyroid problem?

 

Healthcare professionals may check the below panel on patients. Make sure your doctor does the same for you.

 

  • TSH
  • Free T4
  • Free T3
  • Reverse T3
  • Thyroid Peroxidase Antibodies (TPOAb)
  • Thyroglobulin Antibodies (TgAb)

 

What are the Optimal Laboratory Values for Thyroid Tests?

 

In various clinics, it has been discovered that the below list are the ranges in which many patients flourish. These may have been recordeded taking how patients are feeling into account and listening to their patients.

 

  • TSH 1-2 UIU/ML or lower (Armour or compounded T3 can artificially suppress TSH)
  • FT4 >1.1 NG/DL
  • FT3 > 3.2 PG/ML
  • RT3 less than a 10:1 ratio RT3:FT3
  • TPO — TgAb — < 4 IU/ML or negative

 

10 Things to Improve Thyroid Function

 

  • Be certain that you are carrying a high quality multivitamin with Iodine, Zinc, Selenium, Iron, Vitamin D, and B vitamins.
  • Also make sure that your multivitamin contains adequate levels of iodine to aid with the FT4 to FT3 conversion.
  • Go gluten-free. In case you have Hashimoto’s thyroiditis, try going entirely grain and legume.
  • Deal with your stress and support your adrenal glands. The adrenal glands and thyroid work hand and hand. It’s necessary to deal with anxiety using healing yoga and adaptogenic herbs, which support the adrenal glands.
  • Get 8 to 10 hours of sleep per night.
  • Possessing a biological dentist safely remove any amalgam fillings you may have.
  • Watch your intake of cruciferous vegetables. There is a bit of a disagreement.
  • Get fluoride, bromide, and chlorine from your diet and surroundings.
  • Heal your gut. A correctly functioning digestive tract (gut) is essential to good health.
  • Locate a functional medicine doctor and have them operate the above mentioned laboratory test and work with you to find out the root cause of the thyroid imbalance.

Reverse Chronic Illnesses So You Can Take Back Your Health

 

Are you ready to conquer your symptoms, regain your energy, and feel like yourself again? When you have Hashimoto’s, Graves’, or any of the hundreds of other autoimmune disorders, it’s important for you to know that you CAN reverse your affliction. Simply follow a healthcare professional’s advice and take back your health.

 

The scope of our information is limited to chiropractic and spinal injuries and conditions. To discuss options on the subject matter, please feel free to ask Dr. Jimenez or contact us at 915-850-0900 .�
 

By Dr. Alex Jimenez

 

Additional Topics: Wellness

 

Overall health and wellness are essential towards maintaining the proper mental and physical balance in the body. From eating a balanced nutrition as well as exercising and participating in physical activities, to sleeping a healthy amount of time on a regular basis, following the best health and wellness tips can ultimately help maintain overall well-being. Eating plenty of fruits and vegetables can go a long way towards helping people become healthy.

 

blog picture of cartoon paperboy big news

 

TRENDING TOPIC: EXTRA EXTRA: About Chiropractic

 

 

Prevalence of Hypothyroidism on Women | Wellness Clinic

Prevalence of Hypothyroidism on Women | Wellness Clinic

According to the American Accreditation Organization, one in eight women will develop a thyroid disease during their life and as much as 60 percent of those with thyroid disease are unaware of their condition. Undiagnosed thyroid disease may put women at risk for certain acute conditions, such as cardiovascular diseases, infertility and obesity.

 

What are the risks of thyroid disease on women?

 

Pregnant women with undiagnosed or inadequately treated hypothyroidism have an elevated risk of miscarriage, preterm delivery, and severe developmental problems in their children.� The percentage of women who develop thyroid disease includes hyperthyroidism and thyroid cancer. Hypothyroidism, being the most common thyroid disorder.

 

What is Hypothyroidism?

 

Hypothyroidism is when your thyroid gland does not produce enough thyroid hormones. You may suspect you are hypothyroid. Or you may have an investigation. You may find out what to do about it besides taking drugs (thyroid replacement hormone). You might need drugs, but there are quite a few aspects of thyroid health to apply and to find out about. This is true for hypothyroid autoimmune disease, called Hashimoto’s thyroiditis.

 

To start with, what exactly are hypothyroid symptoms?

 

Other symptoms include:

 

  • Depression
  • Can’t conceive, or recurrent miscarriage
  • Sluggish metabolism and constipation
  • Other autoimmune problems: food intolerances (especially wheat), indigestion, bloating, gas
  • Obsessive-compulsive thoughts
  • Can’t lose weight with doing “all the Appropriate things”
  • Brain fog, can’t think straight
  • Skin rashes
  • Frequently getting sick
  • Muscle and joint pain
  • Menstruation is heavy, can be irregular, can wipe out you

 

Common misdiagnoses include:

 

  • Depression
  • Stress
  • Fibromyalgia
  • Unexplained infertility
  • Chronic Fatigue syndrome (CFS)
  • “It is all in your head!”

 

Thyroid Hormones Simplified

 

Your thyroid gland produces a hormone called thyroxine (T4). In addition, it creates some triiodothyronine (T3). T3 is the hormone that your cells utilize. Organs, all cells and cells in your body that is whole utilize T3. Most of the T3 comes into T3. TSH stands for thyroid stimulating hormone. Your pituitary gland, in mind, secretes TSH when thyroid hormones are low. TSH signals your thyroid to put together raw materials, like iodine and tyrosine.

 

Conventional Hypothyroid Diagnosis and Treatment

 

Most licensed medical professionals can dictate thyroid labs. Conventional professionals usually only test TSH and T4. Usually it’s your symptoms that warrant the lab investigation. It may be your gynecologist, or your general practitioner, who first tests your thyroid. If it is favorable these professionals can opt to manage your condition, or they may refer you to an endocrinologist. It is always good to have an endocrinologist in your team, to assess your thyroid.

 

In case you really do have thyroid disease symptoms, your healthcare practitioner might first take a “watch and wait” approach. She’ll prescribe thyroid replacement hormone, if needed. This is the standard care of treatment. The hormone is generally a synthetic T4 (levothyroxin). This treatment assumes that you simply convert T4 to T3 with no problem.

 

Your healthcare practitioner typically won’t offer you much education about the type of hypothyroidism you’ve got, or what to do about it besides just taking thyroid hormone replacement. This is where functional medicine comes in.

 

A Functional Medication Approach on Hypothyroid

 

When women visit a doctor with a hypothyroid identification, they first need to learn if they have autoimmune hypothyroidism (Hashimoto’s). More than 80% of the time, patients don’t understand. This is because they have not been tested for it, or they haven’t been told. The very first thing I do is find out, by testing thyroid antibodies.

 

In conventional medicine, it doesn’t matter whether or not you have unexplained hypothyroid or Hashimoto’s, because the therapy is the same for both: tracking thyroid hormones, and prescribing hormone replacement. In functional medicine, hypothyroid that is unexplained is a totally different state than Hashimoto’s.

 

Unexplained hypothyroidism is often straightforward. Functional medicine practitioners try to find the root cause(s), then cure them. You might not have to take thyroid hormones for the rest of your life. Many women are able to repair hypothyroidism and avoid long-term thyroid replacement hormones.

 

Hashimoto’s rheumatoid arthritis requires a totally different strategy. It is important that you know you can take steps go into remission, and perhaps to slow down the development. Because in case you have one, your odds of developing more of them increases, you are able to prevent further autoimmune diseases.

 

After finding out which type of hypothyroidism which you have, it is imperative to find out what to do. Women do not understand their thyroid condition. That’s why it’s important to seek professional help as soon as possible.

 

The scope of our information is limited to chiropractic and spinal injuries and conditions. To discuss options on the subject matter, please feel free to ask Dr. Jimenez or contact us at 915-850-0900 .�Green-Call-Now-Button-24H-150x150-2.png

 

By Dr. Alex Jimenez

 

Additional Topics: Wellness

 

Overall health and wellness are essential towards maintaining the proper mental and physical balance in the body. From eating a balanced nutrition as well as exercising and participating in physical activities, to sleeping a healthy amount of time on a regular basis, following the best health and wellness tips can ultimately help maintain overall well-being. Eating plenty of fruits and vegetables can go a long way towards helping people become healthy.

 

blog picture of cartoon paperboy big news

 

TRENDING TOPIC: EXTRA EXTRA: About Chiropractic

 

 

Body Composition Evaluation: A Clinical Practice Tool

Body Composition Evaluation: A Clinical Practice Tool

Body Composition: Key Words

  • Fat-free mass
  • Fat mass
  • Undernutrition
  • Bioelectrical impedance analysis
  • Sarcopenic obesity
  • Drug toxicity

Abstract

Undernutrition is insufficiently detected in in- and outpatients, and this is likely to worsen during the next decades. The increased prevalence of obesity together with chronic illnesses associated with fat-free mass (FFM) loss will result in an increased prevalence of sarcopenic obesity. In patients with sarcopenic obesity, weight loss and the body mass index lack accuracy to detect FFM loss. FFM loss is related to increasing mortality, worse clinical outcomes, and impaired quality of life. In sarcopenic obesity and chronic diseases, body composition measurement with dual-energy X-ray absorptiometry, bioelectrical impedance analysis, or computerized tomography quantifies the loss of FFM. It allows tailored nutritional support and disease-specific therapy and reduces the risk of drug toxicity. Body composition evaluation should be integrated into routine clinical practice for the initial assessment and sequential follow-up of nutritional status. It could allow objective, systematic, and early screening of undernutrition and promote the rational and early initiation of optimal nutritional support, thereby contributing to reducing malnutrition-induced morbidity, mortality, worsening of the quality of life, and global health care costs.

Introduction

man overweight 3D modelChronic undernutrition is characterized by a progressive reduction of the�fat-free mass (FFM) and fat mass (FM)�and �which has deleterious consequences on health. Undernutrition is insufficiently screened and treated in hospitalized or at-risk patients despite its high prevalence and negative impact on mortality, morbidity, length of stay (LOS), quality of life, and costs [1�4]. The risk of underestimating hospital undernutrition is likely to worsen in the next decades because of the increasing prevalence of overweight, obesity, and chronic diseases and the increased number of elderly subjects. These clinical conditions are associated with FFM loss (sarcopenia). Therefore, an increased number of patients with FFM loss and sarcopenic obesity will be seen in the future.

Sarcopenic obesity is associated with decreased survival and increased therapy toxicity in cancer patients [5�10], whereas FFM loss is related to decreased survival, a negative clinical outcome, increased health care costs [2], and impaired overall health, functional capacities, and quality of life [4�11]. Therefore, the detection and treatment of FFM loss is a major issue of public health and health costs [12].

Weight loss and the body mass index (BMI) lack sensitivity to detect FFM loss [13]. In this review, we support the systematic assessment of FFM with a method of body composition evaluation in order to improve the detection, management, and follow-up of undernutrition. Such an approach should in turn reduce the clinical and functional consequences of diseases in the setting of a cost- effective medico-economic approach (fig. 1). We discuss the main applications of body composition evaluation in clinical practice (fig. 2).

body composition fig 1

Fig. 1. Conceptualization of the expected impact of early use of body composition for the screening of fat-free loss and�under-nutrition in sarcopenic overweight and obese subjects. An increased prevalence of overweight and obesity is observed in all Western and emerging countries. Simultaneously, the aging of the population, the reduction of the level of physical activity, and the higher prevalence of chronic dis- eases and cancer increased the number of patients with or at risk of FFM impairment, i.e. sarcopenia. Thus, more patients are presenting with �sarcopenic over- weight or obesity�. In these patients, evaluation of nutritional status using anthropometric methods, i.e. weight loss and calculation of BMI, is not sensitive enough to detect FFM impairment. As a result, undernutrition is not detected, worsens, and negatively impacts morbidity, mortality, LOS, length of recovery, quality of life, and health care costs. On the contrary, in patients with �sarcopenic overweight or obesity�, early screening of undernutrition with a dedicated method of body composition evaluation would allow early initiation of nutritional support and, in turn, improvements of nutritional status and clinical outcome.

Rationale for a New Strategy for the Screening of Undernutrition

Screening of Undernutrition Is Insufficient

checklistAcademic societies encourage systematic screening of undernutrition at hospital admission and during the hospital stay [14]. The detection of undernutrition is generally based on measurements of weight and height, calculations of BMI, and the percentage of weight loss. Nevertheless, screening of undernutrition is infrequent in hospitalized or nutritionally at-risk ambulatory patients. For example, in France, surveys performed by the French Health Authority [15] indicate that: (i) weight alone, (ii) weight with BMI or percentage of weight loss, and (iii) weight, BMI,�and percentage of weight loss are reported in only 55, 30, and 8% of the hospitalized patients� records, respectively. Several issues, which could be improved by specific educational programs, explain the lack of implementation of nutritional screening in hospitals (table 1). In addition, the accuracy of the clinical screening of undernutrition could be limited at hospital admission. Indeed, patients with undernutrition may have the same BMI as sex- and age- matched healthy controls but a significantly decreased FFM hidden by an expansion of the FM and the total body water which can be measured by bioelectrical impedance analysis (BIA) [13]. This example illustrates that body composition evaluation allows a more accurate identification of FFM loss than body weight loss or BMI decrease. The lack of sensitivity and specificity of weight, BMI, and percentage of weight loss argue for the need for other methods to evaluate the nutritional status.

Changes in Patients� Profiles

patient consulting a doctorIn 2008, twelve and thirty percent of the worldwide adult population was obese or overweight; this is two times higher than in 1980 [16]. The prevalence of overweight and obesity is also increasing in hospitalized patients. A 10-year comparative survey performed in a European hospital showed an increase in patients� BMI, together with a shorter LOS [17]. The BMI increase masks undernutrition and FFM loss at hospital admission. The increased prevalence of obesity in an aging population has led to the recognition of a new nutritional entity: �sarcopenic obesity� [18]. Sarcopenic obesity is characterized by increased FM and reduced FFM with a normal or high body weight. The emergence of the concept of sarcopenic obesity will increase the number of situations associated with a lack of sensitivity of the calculations of BMI and�body weight change for the early detection of FFM loss. This supports a larger use of body composition evaluation for the assessment and follow-up of nutritional status in clinical practice (fig. 1).

body composition fig 2Fig. 2. Current and potential applications of body composition evaluation in clinical practice. The applications are indicated in the boxes, and the body composition methods that could be used for each application are indicated inside the circles. The most used application of body composition evaluation is the measurement of bone mineral density by DEXA for the diagnosis and management of osteoporosis. Although a low FFM is associated with worse clinical outcomes, FFM evaluation is not yet implemented enough in clinical practice. However, by allowing early detection of undernutrition, body composition evaluation could improve the clinical outcome. Body composition evaluation could also be used to follow up nutritional status, calculate energy needs, tailor nutritional support, and assess fluid changes during perioperative period and renal insufficiency. Recent evidence indicates that�a low FFM is associated with a higher toxicity of some chemo- therapy drugs in cancer patients. Thus, by allowing tailoring of the chemotherapy doses to the FFM in cancer patients, body com- position evaluation should improve the tolerance and the efficacy of chemotherapy. BIA, L3-targeted CT, and DEXA could be used for the assessment of nutritional status, the calculation of energy needs, and the tailoring of nutritional support and therapy. Further studies are warranted to validate BIA as an accurate method for fluid balance measurement. By integrating body composition evaluation into the management of different clinical conditions, all of these potential applications would lead to a better recognition of nutritional care by the medical community, the health care facilities, and the health authorities, as well as to an increase in the medico-economic benefits of the nutritional evaluation.

Body Composition Evaluation For The Assessment Of Nutritional Status

Body composition evaluation is a valuable technique to assess nutritional status. Firstly, it gives an evaluation of nutritional status through the assessment of FFM. Secondly, by measuring FFM and phase angle with BIA, it allows evaluation of the disease prognosis and outcome.

body composition table 1

body composition table 2Body Composition Techniques For FFM Measurement

Body composition evaluation allows measurement of the major body compartments: FFM (including bone mineral tissue), FM, and total body water. Table 2 shows indicative values of the body composition of a healthy subject weighing 70 kg. In several clinical situations, i.e. hospital admission, chronic obstructive pulmonary dis- ease (COPD) [21�23], dialysis [24�26], chronic heart failure [27], amyotrophic lateral sclerosis [28], cancer [5, 29], liver transplantation [30], nursing home residence [31], and Alzheimer�s disease [32], changes in body compartments are detected with the techniques of body composition evaluation. At hospital admission, body composition evaluation could be used for the detection of FFM loss and undernutrition. Indeed, FFM and the FFM index (FFMI) [FFM (kg)/height (m2)] measured by BIA are significantly lower in hospitalized patients (n = 995) than in age-, height-, and sex-matched controls (n = 995) [3]. Conversely, clinical tools of nutritional status assessment, such as BMI, subjective global assessment, or mini-nutritional assessment, are not accurate enough to estimate FFM loss and nutritional status [30, 32�34]. In 441 patients with non-small cell lung cancer, FFM loss deter- mined by computerized tomography (CT) was observed in each BMI category [7], and in young adults with all�types of cancer, an increase in FM together with a de- crease in FFM were reported [29]. These findings reveal the lack of sensitivity of BMI to detect FFM loss. More- over, the FFMI is a more sensitive determinant of LOS than a weight loss over 10% or a BMI below 20 [3]. In COPD, the assessment of FFM by BIA is a more sensitive method to detect undernutrition than anthropometry [33, 35]. BIA is also more accurate at assessing nutrition- al status in children with severe neurologic impairment than the measurement of skin fold thickness [36].

Body Composition For The Evaluation Of Prognosis & Clinical Outcome

FFM loss is correlated with survival in different clinical settings [5, 21�28, 37]. In patients with amyotrophic lateral sclerosis, an FM increase, but not an FFM in- crease, measured by BIA, was correlated with survival during the course of the disease [28]. The relation between body composition and mortality has not yet been demonstrated in the intensive care unit. The relation between body composition and mortality has been demonstrated with anthropometric methods, BIA, and CT. Measurement of the mid-arm muscle circumference is an easy tool to diagnose sarcopenia [38]. The mid-arm muscle circumference has been shown to be correlated with survival in patients with cirrhosis [39, 40], HIV infection [41], and COPD in a stronger way than BMI [42]. The relation between FFM loss and mortality has been extensively shown with BIA [21�28, 31, 37], which is the most used method. Recently, very interesting data suggest that CT could evaluate the disease prognosis in relation to muscle wasting. In obese cancer patients, sarcopenia as assessed by CT measurement of the total skeletal muscle cross-sectional area is an independent predictor of the survival of patients with bronchopulmonary [5, 7], gastrointestinal [5], and pancreatic cancers [6]. FFM assessed by measurement of the mid-thigh muscle cross- sectional area by CT is also predictive of mortality in COPD patients with severe chronic respiratory insufficiency [43]. In addition to mortality, a low FFMI at hospital admission is significantly associated with an in- creased LOS [3, 44]. A bicentric controlled population study performed in 1,717 hospitalized patients indicates that both loss of FFM and excess of FM negatively affect the LOS [44]. Patients with sarcopenic obesity are most at risk of increased LOS. This study also found that ex- cess FM reduces the sensitivity of BMI to detect nutritional depletion [44]. Together with the observation that the BMI of hospitalized patients has increased during the last decade [17], these findings suggest that FFM and�FFMI measurement should be used to evaluate nutritional status in hospitalized patients.

BIA measures the phase angle [45]. A low phase angle is related to survival in oncology [46�50], HIV infection/ AIDS [51], amyotrophic lateral sclerosis [52], geriatrics [53], peritoneal dialysis [54], and cirrhosis [55]. The phase angle threshold associated with reduced survival is variable: less than 2.5 degrees in amyotrophic lateral sclerosis patients [52], 3.5 degrees in geriatric patients [53], from less than 1.65 to 5.6 degrees in oncology patients [47�50], and 5.4 degrees in cirrhotic patients [55]. The phase angle is also associated with the severity of lymphopenia in AIDS [56], and with the risk of postoperative complications among gastrointestinal surgical patients [57]. The relation of phase angle with prognosis and disease severity reinforces the interest in using BIA for the clinical management of patients with chronic diseases at high risk of undernutrition and FFM loss.

In summary, FFM loss or a low phase angle is related to mortality in patients with chronic diseases, cancer (in- cluding obesity cancer patients), and elderly patients in long-stay facilities. A low FFM and an increased FM are associated with an increased LOS in adult hospitalized patients. The relation between FFM loss and clinical out- come is clearly shown in patients with sarcopenic obesity. In these patients, as the sensitivity of BMI for detecting FFM loss is strongly reduced, body composition evalua- tion appears to be the method of choice to detect under- nutrition in routine practice. Overall, the association between body composition, phase angle, and clinical outcome reinforces the pertinence of using a body com- position evaluation in clinical practice.

Which Technique Of Body Composition Evaluation Should Be Used For The Assessment Of Nutritional Status?

Numerous methods of body composition evaluation have been developed: anthropometry, including the 4-skinfold method [58], hydrodensitometry [58], in vivo neutron activation analysis [59], anthropogammametry from total body potassium-40 [60], nuclear magnetic resonance [61], dual-energy X-ray absorptiometry (DEXA) [62, 63], BIA [45, 64�66], and more recently CT [7, 43, 67]. DEXA, BIA, and CT appear to be the most convenient methods for clinical practice (fig. 2), while the other methods are reserved for scientific use.

Compared with other techniques of body composition evaluation, the lack of reproducibility and sensitivity of the 4-skinfold method limits its use for the accurate measurement of body composition in clinical practice [33,�34]. However, in patients with cirrhosis [39, 40], COPD [34], and HIV infection [41], measurement of the mid- arm muscle circumference could be used to assess sarcopenia and disease-related prognosis. DEXA allows non- invasive direct measurement of the three major components of body composition. The measurement of bone mineral tissue by DEXA is used in clinical practice for the diagnosis and follow-up of osteoporosis. As the clinical conditions complicated by osteoporosis are often associated with undernutrition, i.e. elderly women, patients with organ insufficiencies, COPD [68], inflammatory bowel diseases, and celiac disease, DEXA could be of the utmost interest for the follow-up of both osteoporosis and nutritional status. However, the combined evaluation of bone mineral density and nutritional status is difficult to implement in clinical practice because the reduced accessibility of DEXA makes it impossible to be performed in all nutritionally at-risk or malnourished patients. The principles and clinical utilization of BIA have been largely described in two ESPEN position papers [45, 66]. BIA is based on the capacity of hydrated tissues to conduct electrical energy. The measurement of total body impedance allows estimation of total body water by assuming that total body water is constant. From total body water, validated equations allow the calculation of FFM and FM [69], which are interpreted according to reference values [70]. BIA is the only technique which allows calculation of the phase angle, which is correlated with the prognosis of various diseases. BIA equations are valid for: COPD [65]; AIDS wasting [71]; heart, lung, and liver transplantation [72]; anorexia nervosa [73] patients, and elderly subjects [74]. However, no BIA-specific equations have been validated in patients with extreme BMI (less than 17 and higher than 33.8) and dehydration or fluid overload [45, 66]. Nevertheless, because of its simplicity, low cost, quickness of use at bedside, and high interoperator reproducibility, BIA appears to be the technique of choice for the systematic and repeated evaluation of FFM in clinical practice, particularly at hospital admission and in chronic diseases. Finally, through written and objective re- ports, the wider use of BIA should allow improvement of the traceability of nutritional evaluation and an increase in the recognition of nutritional care by the health authorities. Recently, several data have suggested that CT images targeted on the 3rd lumbar vertebra (L3) could strongly predict whole-body fat and FFM in cancer patients, as compared with DEXA [7, 67]. Interestingly, the evaluation of body composition by CT presents great practical significance due to its routine use in patient diagnosis, staging, and follow-up. L3-targeted CT images�evaluate FFM by measuring the muscle cross-sectional area from L3 to the iliac crest by use of Hounsfield unit (HU) thresholds (�29 to +150) [5, 7]. The muscles included in the calculation of the muscle cross-sectional area are psoas, paraspinal muscles (erector spinae, quadratus lumborum), and abdominal wall muscles (transversus abdominis, external and internal obliques, rectus ab- dominis) [6]. CT also provided detail on specific muscles, adipose tissues, and organs not provided by DEXA or BIA. L3-targeted CT images could be theoretically per- formed solely, since they result in X-ray exposition similar to that of a chest radiography.

In summary, DEXA, BIA, and L3-targeted CT images could all measure body composition accurately. The technique selection will depend on the clinical context, hard- ware, and knowledge availability. Body composition evaluation by DEXA should be performed in patients having a routine assessment of bone mineral density. Also, analysis of L3-targeted CT is the method of choice for body composition evaluation in cancer patients. Body composition evaluation should also be done for every abdominal CT performed in patients who are nutritionally at risk or undernourished. Because of its simplicity of use, BIA could be widely implemented as a method of body com- position evaluation and follow-up in a great number of hospitalized and ambulatory patients. Future research will aim to determine whether a routine evaluation of body composition would allow early detection of the in- creased FFM catabolism related to critical illness [75].

Body Composition Evaluation For The Calculation Of Energy Needs

vegetable-juicesThe evaluation of FFM could be used for the calculation of energy needs, thus allowing the optimization of nutritional intakes according to nutritional needs. This could be of great interest in specific situations, such as severe neurologic disability, overweight, and obesity. In 61 children with severe neurologic impairment and intellectual disability, an equation integrating body composition had good agreement with the doubly labeled water method. It gave a better estimation of energy expenditure than did the Schofield predictive equation [36]. However, in 9 anorexia nervosa patients with a mean BMI of 13.7, pre- diction formulas of resting energy expenditure including FFM did not allow accurate prediction of the resting energy expenditure measured by indirect calorimetry [76]. In overweight or obese patients, the muscle catabolism in response to inflammation was the same as that observed�in patients with normal BMI. Indeed, despite a higher BMI, the FFM of overweight or obese individuals is similar (or slightly increased) to that of patients with normal BMI. Thus, the use of actual weight for the assessment of the energy needs of obese patients would result in over- feeding and its related complications. Therefore, the ex- perts recommend the use of indirect calorimetry or calculation of the energy needs of overweight or obese patients as follows: 15 kcal/kg actual weight/day or 20�25 kcal/kg ideal weight/day [77, 78], although these predictive formulas could be inaccurate in some clinical conditions [79]. In a US prospective study conducted in 33 ICU medical and surgical ventilated ICU patients, daily measurement of the active cell mass (table 2) by BIA was used to assess the adequacy between energy/protein intakes and needs. In that study, nutritional support with 30 kcal/ kg actual body weight/day energy and 1.5 g/kg/day protein allowed stabilization of the active cell mass [75]. Thus, follow-up of FFM by BIA could help optimize nutritional intakes when indirect calorimetry cannot be performed.

In summary, the measurement of FFM should help ad- just the calculation of energy needs (expressed as kcal/kg FFM) and optimize nutritional support in critical cases other than anorexia nervosa.

Body Composition Evaluation For The Follow-Up & Tailoring Of Nutritional Support

towel different nutritionBody composition evaluation allows a qualitative assessment of body weight variations. The evaluation of body composition may help to document the efficiency of nutritional support during a patient�s follow-up of numerous clinical conditions, such as surgery [59], anorexia nervosa [76, 80], hematopoietic stem cell transplantation [81], COPD [82], ICU [83], lung transplantation [84], ulcerative colitis [59], Crohn�s disease [85], cancer [86, 87], HIV/AIDS [88], and acute stroke in elderly patients [89]. Body composition evaluation could be used for the follow-up of healthy elderly subjects [90]. Body composition evaluation allows characterization of the increase in body mass in terms of FFM and FM [81, 91]. After hematopoietic stem cell transplantation, the increase in BMI is the result of the increase in FM, but not of the increase in FFM [81]. Also, during recovery after an acute illness, weight gain 6 months after ICU discharge could be mostly related to an increase in FM (+7 kg) while FFM only increased by 2 kg; DEXA and air displacement plethysmography were used to measure the FM and FFM [91]. These two examples suggest that body composition evaluation could be helpful to decide the modification and/or the renewal of nutritional support. By identifying the patients gaining weight but reporting no or insufficient FFM, body composition evaluation could contribute to influencing the medical decision of continuing nutrition- al support that would have been stopped in the absence of body composition evaluation.

In summary, body composition evaluation is of the utmost interest for the follow-up of nutritional support and its impact on body compartments.

Body Composition Evaluation For Tailoring Medical Treatments

In clinical situations when weight and BMI do not reflect the FFM, the evaluation of body composition should be used to adapt drug doses to the FFM and/or FM absolute values in every patient. This point has been recently illustrated in oncology patients with sarcopenic obesity. FFM loss was determined by CT as described above. In cancer patients, some therapies could affect body com- position by inducing muscle wasting [92]. In patients with advanced renal cell carcinoma [92], sorafenib induces a significant 8% loss of skeletal muscular mass at 12 months. In turn, muscle wasting in patients with BMI less than 25 was significantly associated with sorafenib toxicity in patients with metastatic renal cancer [8]. In metastatic breast cancer patients receiving capecitabine treatment, and in patients with colorectal cancer receiving 5-fluorouracile, using the convention of dosing per unit of body surface area, FFM loss was the determinant of chemotherapy toxicity [9, 10] and time to tumor progression [10]. In colorectal cancer patients administered 5-fluoruracil, low FFM is a significant predictor of toxicity only in female patients [9]. The variation in toxicity between women and men may be partially explained by the fact that FFM was lower in females. Indeed, FFM rep- resents the distribution volume of most cytotoxic chemo- therapy drugs. In 2,115 cancer patients, the individual variations in FFM could change by up to three times the distribution volume of the chemotherapy drug per body area unit [5]. Thus, administering the same doses of chemotherapy drugs to a patient with a low FFM compared to a patient with a normal FFM would increase the risk of chemotherapy toxicity [5]. These data suggest that FFM loss could have a direct impact on the clinical outcome of cancer patients. Decreasing chemotherapy doses in case of FFM loss could contribute to improving cancer patients� prognosis through the improvement of the tolerance of chemotherapy. These findings justify the systematic evaluation of body composition in all cancer patients in order to detect FFM loss, tailor chemotherapy doses according to FFM values, and then improve the efficacy- tolerance and cost-efficiency ratios of the therapeutic strategies [93]. Body composition evaluation should also be used to tailor the doses of drugs which are calculated based on patients� weight, e.g. corticosteroids, immuno-suppressors (infliximab, azathioprine or methotrexate), or sedatives (propofol).

In summary, measurement of FFM should be implemented in cancer patients treated with chemotherapy. Clinical studies are needed to demonstrate the importance of measuring body composition in patients treated with other medical treatments.

Towards The Implementation Of Body Composition Evaluation In Clinical Practice

When There's No Cure For Your Aching Back E-book Cover

News Letter

hypertension blood pressure pillsThe implementation of body composition evaluation in routine care presents a challenge for the next decades. Indeed the concomitant increases in elderly subjects and patients with chronic diseases and cancer, and in the prevalence of overweight and obesity in the population, will increase the number of patients nutritionally at risk or undernourished, particularly those with sarcopenic obesity. Body composition evaluation should be used to improve the screening of undernutrition in hospitalized patients. The results of body composition should be based on the same principle as BMI calculation, towards the systematic normalization for body height of FFM (FFMI) and FM [FM (kg)/height (m)2 = FM index] [94]. The results could be expressed according to previously de- scribed percentiles of healthy subjects [95, 96]. Body com- position evaluation should be performed at the different stages of the disease, during the course of treatments and the rehabilitation phase. Such repeated evaluations of body composition could allow assessment of the nutritional status, adjusting the calculation of energy needs as kilocalories/kilogram FFM, following the efficacy of nutritional support, and tailoring drug and nutritional therapies. BIA, L3-targeted CT, and DEXA represent the techniques of choice to evaluate body composition in clinical practice (fig. 2). In the setting of cost-effective and pragmatic use, these three techniques should be alternatively chosen. In cancer, undernourished, and nutritionally at-risk patients, an abdominal CT should be completed by the analysis of L3-targeted images for the evaluation of body composition.

In other situations, BIA appears to be the simplest most reproducible and less expensive method, while DEXA, if feasible, remains the reference method for clinical practice. By allowing earlier management of undernutrition, body composition evaluation can contribute to reducing malnutrition-induced morbidity and mortality, improving the quality of life and, as a consequence, increasing the medico-economic benefits (fig. 1). The latter needs to be demonstrated. Moreover, based on a more scientific approach, i.e. allowing for printing reports, objective initial assessment and follow-up of nutritional status, and the adjustment of drug doses, body composition evaluation would contribute to a better recognition of the activities related to nutritional evaluation and care by the medical community, health care facilities, and health authorities (fig. 2).

Conclusion

woman buying fresh organic vegetables

Screening of undernutrition is insufficient to allow for optimal nutrition care. This is in part due to the lack of sensitivity of BMI and weight loss for detecting FFM loss in patients with chronic diseases. Methods of body com- position evaluation allow a quantitative measurement of FFM changes during the course of disease and could be used to detect FFM loss in the setting of an objective, systematic, and early undernutrition screening. FFM loss is closely related to impaired clinical outcomes, survival, and quality of life, as well as increased therapy toxicity in cancer patients. Thus, body composition evaluation should be integrated into clinical practice for the initial assessment, sequential follow-up of nutritional status, and the tailoring of nutritional and disease-specific therapies. Body composition evaluation could contribute to strengthening the role and credibility of nutrition in the global medical management, reducing the negative impact of malnutrition on the clinical outcome and quality of life, thereby increasing the overall medico-economic benefits.

Acknowledgements

R. Thibault and C. Pichard are supported by research grants from the public foundation Nutrition 2000 Plus.

Disclosure Statement

Ronan Thibault and Claude Pichard declare no conflict of interest.

 

blank
References:

1 Pirlich M, Schutz T, Norman K, Gastell S,
L�bke HJ, Bischoff SC, Bolder U, Frieling
T, G�ldenzoph H, Hahn K, Jauch KW,
Schindler K, Stein J, Volkert D, Weimann A,
Werner H, Wolf C, Z�rcher G, Bauer P, Lochs
H: The German hospital malnutrition study.
Clin Nutr 2006;25:563�572.
2 Amaral TF, Matos LC, Tavares MM, Subtil
A, Martins R, Nazar� M, Sousa Pereira N:
The economic impact of disease-related malnutrition
at hospital admission. Clin Nutr
2007;26:778�784.
3 Pichard C, Kyle UG, Morabia A, Perrier A,
Vermeulen B, Unger P: Nutritional assessment:
lean body mass depletion at hospital
admission is associated with increased
length of stay. Am J Clin Nutr 2004;79:613�
618.
4 Capuano G, Gentile PC, Bianciardi F, Tosti
M, Palladino A, Di Palma M: Prevalence and
influence of malnutrition on quality of life
and performance status in patients with locally
advanced head and neck cancer before
treatment. Support Care Cancer 2010;18:
433�437.
5 Prado CM, Lieffers JR, McCargar LJ, Reiman
T, Sawyer MB, Martin L, Baracos VE: Prevalence
and clinical implications of sarcopenic
obesity in patients with solid tumours of the
respiratory and gastrointestinal tracts: a
population-based study. Lancet Oncol 2008;
9:629�635.
6 Tan BHL, Birdsell LA, Martin L, Baracos VE,
Fearon KC: Sarcopenia in an overweight or
obese patient is an adverse prognostic factor
in pancreatic cancer. Clin Cancer Res 2009;
15:6973�6979.
7 Baracos VE, Reiman T, Mourtzakis M,
Gioulbasanis I, Antoun S: Body composition
in patients with non-small cell lung cancer:
a contemporary view of cancer cachexia
with the use of computed tomography image
analysis. Am J Clin Nutr 2010;91(suppl):
1133S�1137S.
8 Antoun S, Baracos VE, Birdsell L, Escudier
B, Sawyer MB: Low body mass index and sarcopenia
associated with dose-limiting toxicity
of sorafenib in patients with renal cell carcinoma.
Ann Oncol 2010;21:1594�1598
9 Prado CM, Baracos VE, McCargar LJ,
Mourtzakis M, Mulder KE, Reiman T, Butts
CA, Scarfe AG, Sawyer MB: Body composition
as an independent determinant of 5-fluorouracil-based
chemotherapy toxicity. Clin
Cancer Res 2007;13:3264�3268.
10 Prado CM, Baracos VE, McCargar LJ, Reiman
T, Mourtzakis M, Tonkin K, Mackey JR,
Koski S, Pituskin E, Sawyer MB: Sarcopenia
as a determinant of chemotherapy toxicity
and time to tumor progression in metastatic
breast cancer patients receiving capecitabine
treatment. Clin Cancer Res 2009;15:2920�
2926.
11 Hofhuis JG, Spronk PE, van Stel HF, Schrijvers
GJ, Rommes JH, Bakker J: The impact of
critical illness on perceived health-related
quality of life during ICU treatment, hospital
stay, and after hospital discharge: a longterm
follow-up study. Chest 2008;133:377�
385.
12 Guest JF, Panca M, Baeyens JP, de Man F,
Ljungqvist O, Pichard C, Wait S, Wilson L:
Health economic impact of managing patients
following a community-based diagnosis
of malnutrition in the UK. Clin Nutr 2011;
30:422�429.
13 Kyle UG, Morabia A, Slosman DO, Mensi N,
Unger P, Pichard C: Contribution of body
composition to nutritional assessment at
hospital admission in 995 patients: a controlled
population study. Br J Nutr 2001;86:
725�731.
14 Kondrup J, Allison SP, Elia M; Vellas B,
Plauth M: Educational and Clinical Practice
Committee, European Society of Parenteral
and Enteral Nutrition (ESPEN): ESPEN
guidelines for nutrition screening 2002. Clin
Nutr 2003;22:415�421.
15 Haute Autorit� de Sant�: IPAQSS: informations.
2010. www.has-sante.fr/portail/
jcms/c_970427/ipaqss-informations.
16 World Health Organization: Obesity and
overweight: fact sheet No. 311. 2011. http://
www.who.int/mediacentre/factsheets/fs311/
en/index.html.
17 Thibault R, Chikhi M, Clerc A, Darmon P,
Chopard P, Picard-Kossovsky M, Genton L,
Pichard C: Assessment of food intake in hospitalised
patients: a 10 year-comparative
study of a prospective hospital survey. Clin
Nutr 2011;30:289�296.
18 Stenholm S, Harris TB, Rantanen T, Visser
M, Kritchevsky SB, Ferrucci L: Sarcopenic
obesity: definition, cause and consequences.
Curr Opin Clin Nutr Metab Care 2008;11:
693�700.
19 Pichard C, Kyle UG: Body composition measurements
during wasting diseases. Curr
Opin Clin Nutr Metab Care 1998;1:357�361.
20 Wang ZM, Pierson RN Jr, Heymsfield SB:
The five-level model: a new approach to organizing
body-composition research. Am J
Clin Nutr 1992;56:19�28.
21 Schols AM, Broekhuizen R, Weling-Scheepers
CA, Wouters EF: Body composition and
mortality in chronic obstructive pulmonary
disease. Am J Clin Nutr 2005;82:53�59.
22 Slinde F, Gronberg A, Engstrom CP, Rossander-Hulthen
L, Larsson S: Body composition
by bioelectrical impedance predicts
mortality in chronic obstructive pulmonary
disease patients. Respir Med 2005;99:1004�
1009.
23 Vestbo J, Prescott E, Almdal T, Dahl M, Nordestgaard
BG, Andersen T, Sorensen TI,
Lange P: Body mass, fat-free body mass, and
prognosis in patients with chronic obstructive
pulmonary disease from a random population
sample: findings from the Copenhagen
City Heart Study. Am J Respir Crit Care
Med 2006;173:79�83.
24 Segall L, Mardare NG, Ungureanu S, Busuioc
M, Nistor I, Enache R, Marian S, Covic A:
Nutritional status evaluation and survival in
haemodialysis patients in one centre from
Romania. Nephrol Dial Transplant 2009;24:
2536�2540.
25 Beddhu S, Pappas LM, Ramkumar N, Samore
M: Effects of body size and body composition
on survival in hemodialysis patients. J
Am Soc Nephrol 2003;14:2366�2372.
26 F�rstenberg A, Davenport A: Assessment
of body composition in peritoneal dialysis
patients using bioelectrical impedance and
dual-energy X-ray absorptiometry. Am J
Nephrol 2011;33:150�156.
27 Futter JE, Cleland JG, Clark AL: Body mass
indices and outcome in patients with chronic
heart failure. Eur J Heart Fail 2011;13:207�
213.
28 Marin B, Desport JC, Kajeu P, Jesus P, Nicolaud
B, Nicol M, Preux PM, Couratier P: Alteration
of nutritional status at diagnosis is
a prognostic factor for survival of amyotrophic
lateral sclerosis patients. J Neurol
Neurosurg Psychiatry 2011;82:628�634.
29 Janiszewski PM, Oeffinger KC, Church TS,
Dunn AL, Eshelman DA, Victor RG, Brooks
S, Turoff AJ, Sinclair E, Murray JC, Bashore
L, Ross R: Abdominal obesity, liver fat, and
muscle composition in survivors of childhood
acute lymphoblastic leukemia. J Clin
Endocrinol Metab 2007;92:3816�3821.
30 Wagner D, Adunka C, Kniepeiss D, Jakoby
E, Schaffellner S, Kandlbauer M, Fahrleitner-Pammer
A, Roller RE, Kornprat P, M�ller
H, Iberer F, Tscheliessnigg KH: Serum albumin,
subjective global assessment, body
mass index and the bioimpedance analysis in
the assessment of malnutrition in patients up
to 15 years after liver transplantation. Clin
Transplant 2011;25:E396�E400.
31 Kimyagarov S, Klid R, Levenkrohn S, Fleissig
Y, Kopel B, Arad M, Adunsky A: Body
mass index (BMI), body composition and
mortality of nursing home elderly residents.
Arch Gerontol Geriatr 2010;51:227�230.
32 Buffa R, Mereu RM, Putzu PF, Floris G,
Marini E: Bioelectrical impedance vector
analysis detects low body cell mass and dehydration
in patients with Alzheimer�s disease.
J Nutr Health Aging 2010;14:823�827.
33 Schols AM, Wouters EF, Soeters PB, Westerterp
KR: Body composition by bioelectricalimpedance
analysis compared with deuterium
dilution and skinfold anthropometry in
patients with chronic obstructive pulmonary
disease. Am J Clin Nutr 1991;53:421�424.
34 Thibault R, Le Gallic E, Picard-Kossovsky
M, Darmaun D, Chambellan A: Assessment
of nutritional status and body composition
in patients with COPD: comparison of several
methods (in French). Rev Mal Respir
2010;27:693�702.
35 Kyle UG, Janssens JP, Rochat T, Raguso CA,
Pichard C: Body composition in patients
with chronic hypercapnic respiratory failure.
Respir Med 2006;100:244�252.
36 Rieken R, van Goudoever JB, Schierbeek H,
Willemsen SP, Calis EA, Tibboel D, Evenhuis
HM, Penning C: Measuring body composition
and energy expenditure in children with
severe neurologic impairment and intellectual
disability. Am J Clin Nutr 2011;94:759�
766
37 Avram MM, Fein PA, Borawski C, Chattopadhyay
J, Matza B: Extracellular mass/body
cell mass ratio is an independent predictor of
survival in peritoneal dialysis patients. Kidney
Int Suppl 2010;117:S37�S40.
38 Frisancho AR: New norms of upper limb fat
and muscle areas for assessment of nutritional
status. Am J Clin Nutr 1981;34:2540�2545.
39 Caregaro L, Alberino F, Amodio P, Merkel C,
Bolognesi M, Angeli P, Gatta A: Malnutrition
in alcoholic and virus-related cirrhosis.
Am J Clin Nutr l996;63:602�609.
40 Alberino F, Gatta A, Amodio P, Merkel C, Di
Pascoli L, Boffo G, Caregaro L: Nutrition and
survival in patients with liver cirrhosis. Nutrition
2001;17:445�450.
41 Liu E, Spiegelman D, Semu H, Hawkins C,
Chalamilla G, Aveika A, Nyamsangia S,
Mehta S, Mtasiwa D, Fawzi W: Nutritional
status and mortality among HIV-infected
patients receiving antiretroviral therapy in
Tanzania. J Infect Dis 2011;204:282�290.
42 Soler-Cataluna JJ, Sanchez-Sanchez L, Martinez-Garcia
MA, Sanchez PR, Salcedo E,
Navarro M: Mid-arm muscle area is a better
predictor of mortality than body mass index
in COPD. Chest 2005;128:2108�2115.
43 Marquis K, Debigar� R, Lacasse Y, LeBlanc P,
Jobin J, Carrier G, Maltais F: Midthigh muscle
cross-sectional area is a better predictor
of mortality than body mass index in patients
with chronic obstructive pulmonary
disease. Am J Respir Crit Care Med 2002;15;
166:809�813.
44 Kyle UG, Pirlich M, Lochs H, Schuetz T, Pichard
C: Increased length of hospital stay in
underweight and overweight patients at hospital
admission: a controlled population
study. Clin Nutr 2005;24:133�142.
45 Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg
P, Elia M, G�mez JM, Heitmann
BL, Kent-Smith L, Melchior JC, Pirlich M,
Scharfetter H, Schols AM, Pichard C, Composition
of the ESPEN Working Group. Bioelectrical
impedance analysis. 1. Review of
principles and methods. Clin Nutr 2004;23:
1226�1243.
46 Santarpia L, Marra M, Montagnese C, Alfonsi
L, Pasanisi F, Contaldo F: Prognostic
significance of bioelectrical impedance
phase angle in advanced cancer: preliminary
observations. Nutrition 2009;25:930�931.
47 Gupta D, Lammersfeld CA, Vashi PG, King
J, Dahlk SL, Grutsch JF, Lis CG: Bioelectrical
impedance phase angle in clinical practice:
implications for prognosis in stage IIIB and
IV non-small cell lung cancer. BMC Cancer
2009;9:37.
48 Gupta D, Lis CG, Dahlk SL, Vashi PG,
Grutsch JF, Lammersfeld CA: Bioelectrical
impedance phase angle as a prognostic indicator
in advanced pancreatic cancer. Br J
Nutr 2004;92:957�962.
49 Gupta D, Lammersfeld CA, Burrows JL,
Dahlk SL, Vashi PG, Grutsch JF, Hoffman S,
Lis CG: Bioelectrical impedance phase angle
in clinical practice: implications for prognosis
in advanced colorectal cancer. Am J Clin
Nutr 2004;80:1634�1638.
50 Paiva SI, Borges LR, Halpern-Silveira D, Assun��o
MC, Barros AJ, Gonzalez MC: Standardized
phase angle from bioelectrical impedance
analysis as prognostic factor for
survival in patients with cancer. Support
Care Cancer 2010;19:187�192.
51 Schwenk A, Beisenherz A, R�mer K, Kremer
G, Salzberger B, Elia M: Phase angle from
bioelectrical impedance analysis remains an
independent predictive marker in HIV-infected
patients in the era of highly active antiretroviral
treatment. Am J Clin Nutr 2000;
72:496�501.
52 Desport JC, Marin B, Funalot B, Preux PM,
Couratier P: Phase angle is a prognostic factor
for survival in amyotrophic lateral sclerosis.
Amyotroph Lateral Scler 2008;9:273�
278.
53 Wirth R, Volkert D, R�sler A, Sieber CC,
Bauer JM: Bioelectric impedance phase angle
is associated with hospital mortality of
geriatric patients. Arch Gerontol Geriatr
2010;51:290�294.
54 Mushnick R, Fein PA, Mittman N, Goel N,
Chattopadhyay J, Avram MM: Relationship
of bioelectrical impedance parameters to nutrition
and survival in peritoneal dialysis patients.
Kidney Int Suppl 2003;87:S53�S56.
55 Selberg O, Selberg D: Norms and correlates
of bioimpedance phase angle in healthy human
subjects, hospitalized patients, and patients
with liver cirrhosis. Eur J Appl Physiol
2002;86:509�516.
56 Shah S, Whalen C, Kotler DP, Mayanja H,
Namale A, Melikian G, Mugerwa R, Semba
RD: Severity of human immunodeficiency
virus infection is associated with decreased
phase angle, fat mass and body cell mass in
adults with pulmonary tuberculosis infection
in Uganda. J Nutr 2001;131:2843�2847.
57 Barbosa-Silva MC, Barros AJ: Bioelectric impedance
and individual characteristics as
prognostic factors for post-operative complications.
Clin Nutr 2005;24:830�838.
58 Durnin JV, Womersley J: Body fat assessed
from total body density and its estimation
from skinfold thickness: measurements on
481 men and women aged from 16 to 72
years. Br J Nutr 1974;32:77�97.
59 Hill GL: Body composition research: implications
for the practice of clinical nutrition.
JPEN J Parenter Enter Nutr 1992;16:197�218.
60 Pierson RN Jr, Wang J, Thornton JC, Van
Itallie TB, Colt EW: Body potassium by fourpi
40K counting: an anthropometric correction.
Am J Physiol 1984;246:F234�F239.
61 Sohlstr�m A, Forsum E: Changes in total
body fat during the human reproductive cycle
as assessed by magnetic resonance imaging,
body water dilution, and skinfold thickness:
a comparison of methods. Am J Clin
Nutr 1997;66:1315�1322.
62 Leonard CM, Roza MA, Barr RD, Webber
CE: Reproducibility of DXA measurements
of bone mineral density and body composition
in children. Pediatr Radiol 2009;39:148�
154.
63 Genton L, Karsegard VL, Zawadynski S, Kyle
UG, Pichard C, Golay A, Hans DB: Comparison
of body weight and composition measured
by two different dual energy X-ray absorptiometry
devices and three acquisition
modes in obese women. Clin Nutr 2006;25:
428�437.
64 Jaffrin MY: Body composition determination
by bioimpedance: an update. Curr Opin
Clin Nutr Metab Care 2009;12:482�486.
65 Kyle UG, Pichard C, Rochat T, Slosman DO,
Fitting JW, Thiebaud D: New bioelectrical
impedance formula for patients with respiratory
insufficiency: comparison to dual-energy
X-ray absorptiometry. Eur Respir J 1998;
12:960�966.
66 Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg
P, Elia M, Manuel G�mez J, Lilienthal
Heitmann B, Kent-Smith L, Melchior
JC, Pirlich M, Scharfetter H, Schols AMWJ,
Pichard C, ESPEN: Bioelectrical impedance
analysis. 2. Utilization in clinical practice.
Clin Nutr 2004;23:1430�1453.
67 Mourtzakis M, Prado CM, Lieffers JR, Reiman
T, McCargar LJ, Baracos VE: A practical
and precise approach to quantification of
body composition in cancer patients using
computed tomography images acquired during
routine care. Appl Physiol Nutr Metab
2008;33:997�1006.
68 Bolton CE, Ionescu AA, Shiels KM, Pettit RJ,
Edwards PH, Stone MD, Nixon LS, Evans
WD, Griffiths TL, Shale DJ: Associated loss
of fat-free mass and bone mineral density in
chronic obstructive pulmonary disease. Am
J Respir Crit Care Med 2004;170:1286�1293.
69 Kyle UG, Genton L, Karsegard L, Slosman
DO, Pichard C: Single prediction equation
for bioelectrical impedance analysis in
adults aged 20�94 years. Nutrition 2001;17:
248�253.
70 Kyle UG, Genton L, Slosman DO, Pichard C:
Fat-free and fat mass percentiles in 5,225
healthy subjects aged 15 to 98 years. Nutrition
2001;17(7�8):534�541.
71 Kotler DP, Burastero S, Wang J, Pierson RN
Jr: Prediction of body cell mass, fat-free
mass, and total body water with bioelectrical
impedance analysis: effects of race, sex, and
disease. Am J Clin Nutr 1996;64:489S�497S.
72 Kyle UG, Genton L, Mentha G, Nicod L, Slosman
DO, Pichard C: Reliable bioelectrical
impedance analysis estimate of fat-free mass
in liver, lung, and heart transplant patients.
JPEN J Parenter Enteral Nutr 2001;25:45�51.
73 Mattar L, Godart N, Melchior JC, Falissard
B, Kolta S, Ringuenet D, Vindreau C, Nordon
C, Blanchet C, Pichard C: Underweight
patients with anorexia nervosa: comparison
of bioelectrical impedance analysis using
five equations to dual X-ray absorptiometry.
Clin Nutr 2011, E-pub ahead of print.
74 Genton L, Karsegard VL, Kyle UG, Hans DB,
Michel JP, Pichard C: Comparison of four
bioelectrical impedance analysis formulas in
healthy elderly subjects. Gerontology 2001;
47:315�323.
75 Robert S, Zarowitz BJ, Hyzy R, Eichenhorn
M, Peterson EL, Popovich J Jr: Bioelectrical
impedance assessment of nutritional status
in critically ill patients. Am J Clin Nutr 1993;
57:840�844.
76 Pichard C, Kyle UG, Slosman DO, Penalosa
B: Energy expenditure in anorexia nervosa:
can fat-free mass as measured by bioelectrical
impedance predict energy expenditure in
hospitalized patients? Clin Nutr 1996;15:
109�114.
77 Kreymann KG, Berger MM, Deutz NE, Hiesmayr
M, Jolliet P, Kazandjiev G, Nitenberg
G, van den Berghe G, Wernerman J, DGEM
(German Society for Nutritional Medicine),
Ebner C, Hartl W, Heymann C, Spies C, ESPEN:
ESPEN guidelines on enteral nutrition:
intensive care. Clin Nutr 2006;25:210�223.
78 Singer P, Berger MM, van den Berghe G, Biolo
G, Calder P, Forbes A, Griffiths R, Kreyman
G, Leverve X, Pichard C, ESPEN: ESPEN
guidelines on parenteral nutrition: intensive
care. Clin Nutr 2009;28:387�400.
79 Magnuson B, Peppard A, Auer Flomenhoft
D: Hypocaloric considerations in patients
with potentially hypometabolic disease
states. Nutr Clin Pract 2011;26:253�260.
80 Rigaud D, Boulier A, Tallonneau I, Brindisi
MC, Rozen R: Body fluid retention and body
weight change in anorexia nervosa patients
during refeeding. Clin Nutr 2010;29:749�
755.
81 Kyle UG, Chalandon Y, Miralbell R, Karsegard
VL, Hans D, Trombetti A, Rizzoli R,
Helg C, Pichard C: Longitudinal follow-up of
body composition in hematopoietic stem cell
transplant patients. Bone Marrow Transplant
2005;35:1171�1177.
82 Pison CM, Cano NJ, Cherion C, Caron F,
Court-Fortune I, Antonini M, GonzalezBermejo
J, Meziane L, Molano LC, Janssens
JP, Costes F, Wuyam B, Similowski T, Melloni
B, Hayot M, Augustin J, Tardif C,
Lejeune H, Roth H, Pichard C, the IRAD Investigators:
Multimodal nutritional rehabilitation
improves clinical outcomes of malnourished
patients with chronic respiratory
failure: a controlled randomised trial. Thorax
2011;66:953�960.
83 Pichard C, Kyle U, Chevrolet JC, Jolliet P,
Slosman D, Mensi N, Temler E, Ricou B: Lack
of effects of recombinant growth hormone
on muscle function in patients requiring
prolonged mechanical ventilation: a prospective,
randomized, controlled study. Crit
Care Med 1996;24:403�413.
84 Pichard C, Kyle UG, Jolliet P, Slosman DO,
Rochat T, Nicod L, Romand J, Mensi N,
Chevrolet JC: Treatment of cachexia with recombinant
growth hormone in a patient before
lung transplantation: a case report. Crit
Care Med 1999;27:1639�1642.
85 Leslie WD, Miller N, Rogala L, Bernstein
CN: Body mass and composition affect bone
density in recently diagnosed inflammatory
bowel disease: the Manitoba IBD Cohort
Study. Inflamm Bowel Dis 2009;15:39�46.
86 van der Meij BS, Langius JA, Smit EF,
Spreeuwenberg MD, von Blomberg BM,
Heijboer AC, Paul MA, van Leeuwen PA:
Oral nutritional supplements containing (n-
3) polyunsaturated fatty acids affect the nutritional
status of patients with stage III nonsmall
cell lung cancer during multimodality
treatment. J Nutr 2010;140:1774�1780.
87 Ryan AM, Reynolds JV, Healy L, Byrne M,
Moore J, Brannelly N, McHugh A, McCormack
D, Flood P: Enteral nutrition enriched
with eicosapentaenoic acid (EPA) preserves
lean body mass following esophageal cancer
surgery: results of a double-blinded randomized
controlled trial. Ann Surg 2009;249:
355�363.
88 Ndekha MJ, Oosterhout JJ, Zijlstra EE, Manary
M, Saloojee H, Manary MJ: Supplementary
feeding with either ready-to-use fortified
spread or corn-soy blend in wasted
adults starting antiretroviral therapy in Malawi:
randomised, investigator blinded, controlled
trial. BMJ 2009;338:b1867�b1875.
89 Ha L, Hauge T, Iversen PO: Body composition
in older acute stroke patients after treatment
with individualized, nutritional supplementation
while in hospital. BMC Geriatrics
2010;10:75.
90 Genton L, Karsegard VL, Chevalley T, Kossovsky
MP, Darmon P, Pichard C: Body
composition changes over 9 years in
healthy elderly subjects and impact of physical
activity. Clin Nutr 2011;30:436�442.
91 Reid CL, Murgatroyd PR, Wright A, Menon
DK: Quantification of lean and fat tissue repletion
following critical illness: a case report.
Crit Care 2008;12:R79.
92 Antoun S, Birdsel Ll, Sawyer MB, Venner P,
Escudier B, Baracos VE: Association of skeletal
muscle wasting with treatment with
sorafenib in patients with advanced renal
cell carcinoma: results from a placebo-controlled
study. J Clin Oncol 2010;28:1054�
1060.
93 Prado CM, Antoun S, Sawyer MB, Baracos
VE: Two faces of drug therapy in cancer:
drug-related lean tissue loss and its adverse
consequences to survival and toxicity. Curr
Opin Clin Nutr Metab Care 2011;14:250�
254.
94 Schutz Y, Kyle UG, Pichard C: Fat-free mass
index and fat mass index percentiles in Caucasians
aged 18�98 y. Int J Obes 2002;26:
953�960.
95 Kyle UG, Schutz Y, Dupertuis YM, Pichard
C: Body composition interpretation: contributions
of the fat-free mass index and the
body fat mass index. Nutrition 2003;19:597�
604.
96 Kyle UG, Piccoli A, Pichard C: Body composition
measurements: interpretation finally
made easy for clinical use. Curr Opin Clin
Nutr Metab Care 2003;6:387�393.

Close Accordion
Why Diabetes Medications Can Be Harmful | Wellness Clinic

Why Diabetes Medications Can Be Harmful | Wellness Clinic

More than 29 million people in the United States have been previously diagnosed with diabetes, and unfortunately, that number grows by approximately 1.4 million annually. What’s the prevalence of diabetes today?

 

We all know someone who has diabetes. A lot of us even have family members who have been diagnosed with the condition. In the past, children who were often diagnosed with diabetes had Type 1 diabetes with Type 2 diabetes occurring during maturity. Today, snacks and processed foods which are high in simple carbs are eaten by kids on a regular basis. They additionally lead less physically active lifestyles. This has resulted in an increasing number of children being diagnosed with Type 2 diabetes than ever before in the United States.

 

Common Diabetes Medicine and its Effects

 

Many people who develop diabetes don’t even realize they have the disease. Of many of these individuals diagnoses, a good majority will probably be given one or more types of diabetes drugs. Some medications help the body become more sensitive to insulin. Others help the body make more insulin on its own.

 

Metformin is usually the first medication prescribed to treat Type 2 diabetes. Sometimes this drug is prescribed as a preventive measure for patients who are considered “borderline” diabetics. Metformin is regarded as the safest option in diabetes drugs and medications. However, it has been recorded to cause vomiting, nausea, breathing difficulty, irregular or slow heartbeat, severe stomach cramps, muscle pain, fatigue, and drowsiness.

 

Advanced Drugs Hold an Even Greater Risk of Side Effects

 

Modern medications designed to treat diabetes include:

 

  • Sulfonylureas, that help your body produce more insulin. These drugs can cause low blood sugar, hunger and weight gain, changes in urine color, upset stomach, and skin reactions.
  • Meglitinides, which stimulate the pancreas to increase insulin production but with faster acting results than with sulfonylureas. This category of drugs may lead to temporary hair loss, back pain, headache, cold or flu-like symptoms, diarrhea, nausea, and joint pain.
  • GLP-1 receptor agonists slow digestion to reduce blood glucose. These medications have minimal impact, so they are usually utilized in combination. GLP-1 medications may lead to gastrointestinal side effects.
  • Thiazolidinediones, which increase insulin sensitivity. These medications are linked to a rise in the risk of fractures and heart failure. Other negative effects include painful urination and/or blood in the urine, shortness of breath, stomach pain, swelling, chest pain, rapid weight reduction, and the sensation of being ill.
  • DPP-4 inhibitors, which lower blood sugar levels minimally. These medicines can cause flu-like symptoms, gastrointestinal problems, and debilitating skin reactions.
  • SGLT2 inhibitors, which cause sugar to be excreted in the urine rather than being absorbed by the kidneys. This category of drugs can lead to urinary tract infections, upper respiratory tract infections, an increase in high blood cholesterol, increased genital yeast infections, diabetic ketoacidosis, hypoglycemia, and urination.
  • Insulin, that is used less often for patients with Type 2 diabetes than with Type 1. In treating patients with Type 2 than with Type 1, insulin is usually regarded as a last resort. The side effects include severe hypoglycemia which could result in seizures, coma, permanent deficits, cardiac arrhythmia, and departure.

 

Invokana Diabetes Drug Effects and Risks

 

There is more to be concerned about compared to the known side effects of a drug. The SGLT-2 drug Invokana is a perfect illustration of the true hazards of diabetes medication. The Federal Drug Administration (FDA) has given the drug a Black Box Warning for the increased risk of leg and foot amputations linked to the drug’s use.

 

Research repeatedly shows that diabetes drugs may be more hazardous than the actual disease. Diabetes drugs work differently, but they’re all designed to treat the outward signs of the disease. Case studies and research have shown that staying active, eating a healthy diet, and correcting the root causes are the best approach to address and to stop type 2 diabetes. Diabetes medications, on the other hand, can cause acute side-effects while only treating the symptoms.

 

The scope of our information is limited to chiropractic and spinal injuries and conditions. To discuss options on the subject matter, please feel free to ask Dr. Jimenez or contact us at 915-850-0900 .�
 

By Dr. Alex Jimenez

 

Additional Topics: Wellness

 

Overall health and wellness are essential towards maintaining the proper mental and physical balance in the body. From eating a balanced nutrition as well as exercising and participating in physical activities, to sleeping a healthy amount of time on a regular basis, following the best health and wellness tips can ultimately help maintain overall well-being. Eating plenty of fruits and vegetables can go a long way towards helping people become healthy.

 

blog picture of cartoon paperboy big news

 

TRENDING TOPIC: EXTRA EXTRA: About Chiropractic